General Information of the Protein
Protein ID |
PT00985
|
||||
---|---|---|---|---|---|
Protein Name |
Cell division cycle 7-related protein kinase
|
||||
Gene Name |
CDC7
|
||||
Secondarily Gene Name |
CDC7L1
|
||||
Sequence |
MEASLGIQMDEPMAFSPQRDRFQAEGSLKKNEQNFKLAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKSHIITGNKIPLSGPVPKELDQQSTTKASVKRPYTNAQIQIKQGKDGKEGSVGLSVQRSVFGERNFNIHSSISHESPAVKLMKQSKTVDVLSRKLATKKKAISTKVMNSAVMRKTASSCPASLTCDCYATDKVCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHASHQPAISEKTDHKASCLVQTPPGQYSGNSFKKGDSNSCEHCFDEYNTNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Enzyme
>
Kinase
>
Protein Kinase
>
Other protein kinase group
>
Other protein kinase CDC7 family
|
||||
Function |
Kinase involved in initiation of DNA replication. Phosphorylates critical substrates that regulate the G1/S phase transition and initiation of DNA replication, such as MCM proteins and CLASPIN.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Nucleus
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000034 , Caco-2
Compound ID | Compound Name | Compound Formula | |
CP0029051 |
8-chloro-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one
Show/Hide
|
C14H12ClN3O2
|
1 |
1 |
IC50 = 140 nM
|
TI
LI
LO
TS
|
---|
Cell Line ID: CL000067 , HCT 116
Cell Line ID: CL000017 , HeLa
Cell Line ID: CL000111 , MDA-MB-231
Biochemical Assays
Clinical Information about the Protein
Target 1 ( CDC7-related kinase (CDC7) )
Target Type | Clinical trial Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Haematological malignancy [ICD-11: 2B33.Y] | ||||
2 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | BMS-863233 | Phase 1/2 | |||
2 | TAK-931 | Phase 1 |